Typhoid Vi Conjugate Vaccine IP

Trade Name: Typbar TCV
Strength / Pack Size : 0.5 mL
Key Ingredients : It contains purified Vi capsular polysaccharide of Salmonella enterica serovar Typhi Ty2 conjugated to a tetanus toxoid carrier protein.
Packaging : 1 x 0.5 mL
Pack Insert/Leaflet : YES
Therapeutic use : Typbar TCV Vaccine is a typhoid vaccine recommended for the prevention of typhoid fever. Typbar TCV Vaccine works by causing the body to produce its own protection (antibodies) against the bacteria. This vaccine is generally recommended for individuals who are traveling to areas where typhoid fever is common.
Capacity : 1000

Our team is available 24/7 to help with your enquiry.

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast, etc.

Europe: Austria, Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK), Latvia, etc.

Oceania: Australia, New Zealand, Fiji, etc.